[Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced*; D000965:Antimony / Q000009:adverse effects*; D000981:Antiprotozoal Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy*; D008536:Meglumine; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds
D000981:Antiprotozoal Agents; D009942:Organometallic Compounds; D008536:Meglumine; D000077485:Meglumine Antimoniate; D000965:Antimony
Agranulocitosis por glucantime (antimoniato de N-metilglucamina) durante el tratamiento del kala-azar.